Goodwin Procter advised Genfit on the deal.Genfit entered into a licensing agreement with Genoscience Pharma for exclusive right to develop and commercialize the investigational treatment GNS561…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
